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1. Materials and Methods.Unless otherwise stated, reactions were performed under a nitrogen 
atmosphere using freshly dried solvents. Methylene chloride, diethyl ether, tetrahydrofuran, and 
toluene were dried by passing through activated alumina. All other commercially obtained 
reagents were used as received unless specifically indicated. Aryl iodides were purchased from 
Sigma Aldrich, Combi-Blocks, or Astatech. Manganese powder (>99.9%) was purchased from 
Sigma Aldrich. NiCl2(dme) was purchased from Strem. Ghaffar-Parkins catalyst was purchased 
from Strem. All reactions were monitored by thin-layer chromatography using EMD/Merck 
silica gel 60 F254 pre-coated plates (0.25 mm). Silica gel column chromatography was 
performed as described by Still et al. (W. C. Still, M. Kahn, A. Mitra, J. Org. Chem. 1978, 43, 
2923.) using silica gel (particle size 0.032-0.063) purchased from Silicycle. 1H and 13C NMR 
were recorded on a Varian Inova 500 (at 500 MHz and 125 MHz respectively) or a Varian Inova 
600 (at 600 MHz and 150 MHz respectively, and are reported relative to internal chloroform (1H, 
δ = 7.26, 13C, δ = 77.0).  Data for 1H NMR spectra are reported as follows: chemical shift (δ 
ppm) (multiplicity, coupling constant (Hz), integration). Multiplicity and qualifier abbreviations 
are as follows: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad. IR 
spectra were recorded on a Perkin Elmer Paragon 1000 spectrometer and are reported in 
frequency of absorption (cm–1). Analytical SFC was performed with a Mettler SFC supercritical 
CO2 analytical chromatography system with Chiralcel AD-H, OD-H, AS-H, OB-H, and IA 
columns (4.6 mm x 25 cm).  HRMS were acquired using either an Agilent 6200 Series TOF with 
an Agilent G1978A Multimode source in electrospray ionization (ESI), atmospheric pressure 
chemical ionization (APCI), or mixed (MM) ionization mode. Low-temperature X-ray 
diffraction data (φ-and ω-scans) were collected on a Bruker AXS D8 VENTURE KAPPA 
diffractometer coupled to a PHOTON 100 CMOS detector with Cu-Kα radiation (λ = 1.54178 
Å) from an IµS micro-source.  
 
Abbreviations used: IPA – isopropanol; Et2O – diethyl ether; PhMe – toluene; EtOAc – ethyl 
acetate; DCM – dichloromethane; N,N’-DMEDA – N,N’-dimethylethylenediamine;  ee – 
enantiomeric excess. 
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2. Catalyst and Substrate Preparation. 
a. Preparation of (S)-4-benzyl-2-(2-(bis(4-methoxy-3,5-
dimethylphenyl)phosphanyl)phenyl)-4,5-dihydrooxazole (L6, DMMBnPHOX) 
 
P N
O
Bn
MeO
Me
Me
Me
OMe
Me
CuI (0.13 equiv)
N,N'-DMEDA (0.88 equiv)
Cs2CO3 (3.75 equiv)
PhMe, 110 ºC, 16 h
Br N
O
Bn
P
H
Me
MeO
Me Me
OMe
Me
S1
1.8 equiv.
+
S2 L6
 
To a flame-dried flask was added CuI (0.13 equiv, 241 mg, 1.3 mmol), followed by anhydrous 
toluene (40 mL). To this solution was added N,N’-DMEDA (0.88 equiv, 0.93 mL, 8.6 mmol) 
and diarylphosphine S1 (1.8 equiv, 5.3 g, 17.5 mmol). These were stirred for 15 minutes at room 
temperature. To the reaction was then added Cs2CO3 (3.75 equiv, 12.4 g, 36.7 mmol), followed 
by bromoarene S2 (1 equiv, 3.1 g, 9.8 mmol) as a solution in toluene (40 mL). The reaction was 
heated to 110 ºC for 16 h. After cooling to room temperature, the reaction was filtered through a 
plug of Celite and washed with degassed anhydrous DCM. The solution was concentrated and 
quickly purified via column chromatography using a positive pressure of argon and degassed 
solvent (10-40% Et2O/Hexanes) to afford L6 as a white foamy solid (1.62 g, 3.01 mmol, 31% 
yield). 1H NMR (500 MHz, Chloroform-d) δ 7.90 – 7.82 (m, 1H), 7.40 – 7.32 (m, 2H), 7.32 – 
7.27 (m, 2H), 7.26 – 7.20 (m, 1H), 7.15 – 7.10 (m, 2H), 7.05 (dd, J = 12.7, 7.9 Hz, 4H), 6.93 
(ddd, J = 7.7, 4.5, 1.5 Hz, 1H), 4.44 – 4.29 (m, 1H), 4.06 (dd, J = 9.3, 8.3 Hz, 1H), 3.78 (dd, J = 
8.4, 7.4 Hz, 1H), 3.75 (d, J = 4.0 Hz, 6H), 2.99 (dd, J = 13.7, 5.0 Hz, 1H), 2.28 (d, J = 13.0 Hz, 
12H), 2.17 – 2.06 (m, 1H); 13C NMR (126 MHz, cdcl3) 13C NMR (126 MHz, cdcl3) δ 164.32, 
164.30, 157.71, 157.63, 139.88, 139.68, 138.19, 135.02, 134.84, 134.72, 134.54, 133.40, 133.38, 
132.43, 132.41, 132.36, 132.33, 131.49, 131.35, 131.01, 130.95, 130.90, 130.83, 130.36, 129.91, 
129.89, 129.08, 128.48, 127.65, 126.34, 71.55, 67.90, 59.68, 59.62, 41.25, 16.22, 16.17; 31P 
NMR (121 MHz, cdcl3) δ -6.15; IR (NaCl/thin film): 3564.92, 2935.84, 1651.78, 1474.78, 
1274.72, 1217.33, 1113.02, 1014.45, 909.83, 732.11, 700.48, 607.77 cm-1; [α]D25 = +37.355 (c = 
1.285, CHCl3). HRMS (MM) calc’d for [M+H2O]+ 555.2533, found 555.2544. 
 
b. General procedure 1 for preparation of heteroaryl iodides. 
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To a flame-dried flask was added copper(I) iodide (0.05 equiv), followed by 1,4-dioxane and 
N,N’-DMEDA (0.10 equiv), then aryl bromide (1.0 equiv) and sodium iodide (2.0 equiv). The 
reaction was heated to 110 ºC for 24 h. Upon cooling to room temperature, the reaction was 
filtered over Celite and washed with DCM. The solution was concentrated to afford the aryl 
iodide as a light solid. Purification by recrystallization was possible for all substrates but was 
generally unnecessary. Aryl iodides were employed in the coupling reactions as is.  
 
5-iodo-2-phenylthiopyrimidine (6j) 
Prepared from 5-bromo-2-phenylthiopyrimidine (10.3 mmol, 2.75 g) following 
General Procedure 1 to yield 3.14 g (97% yield) of 6j as a light tan solid. 1H 
NMR (500 MHz, Chloroform-d) δ 8.62 (s, 2H), 7.65 – 7.56 (m, 2H), 7.48 – 
7.40 (m, 3H); 13C NMR (126 MHz, cdcl3) δ 171.40, 162.64, 135.25, 129.61, 129.34, 128.88, 
87.17; IR (NaCl/thin film): 3057.57, 1537.84, 1514.30, 1440.03, 1382.13, 1184.77, 994.96, 
745.51, 687.91, 630.05 cm-1; HRMS (MM) calc’d for [M]+ 313.9369, found 313.9579. 
 
5-iodo-2-(piperidin-1-yl)pyrimidine (6k) 
 Prepared from 5-bromo-2-(piperidin-1-yl)pyrimidine (10.3 mmol, 2.49 g) 
following General Procedure 1 to yield 2.86 g (96% yield) of 6k as a light 
yellow solid. 1H NMR (500 MHz, Chloroform-d) δ 8.34 (s, 2H), 3.78 – 3.69 
(m, 4H), 1.71 – 1.63 (m, 2H), 1.59 (tt, J = 7.8, 4.5 Hz, 4H); 13C NMR (126 
MHz, cdcl3) δ 162.34, 159.63, 74.30, 44.87, 25.64, 24.71; IR (NaCl/thin film): 2929.42, 2849.82, 
1558.04, 1505.31, 1360.11, 1266.59, 1253.66, 1023.84, 945.12, 851.36, 784.80, 642.34 cm-1; 
HRMS (MM) calc’d for [M]+ 289.0070, found 289.0033. 
 
5-iodo-2-(pyrrolidin-1-yl)pyrimidine (6l) 
 Prepared from 5-bromo-2-(pyrrolidin-1-yl)pyrimidine (10.3 mmol, 2.35 g) 
following General Procedure 1 to yield 2.75 g (97% yield) of 6l as a very 
light pink solid. 1H NMR (500 MHz, Chloroform-d) δ 8.37 (s, 2H), 3.57 – 
3.47 (m, 4H), 2.18 – 1.77 (m, 4H); 13C NMR (126 MHz, cdcl3) δ 162.34, 
158.19, 74.37, 46.74, 25.52; IR (NaCl/thin film): 2944.10, 2864.32, 1565.22, 1518.02, 1511.96, 
N
NPhS
I
N
NN
I
N
N
I
N
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1333.11, 1286.14, 1153.17, 940.39, 782.61, 639.66 cm-1; HRMS (MM) calc’d for [M]+ 
274.9914, found 274.9874. 
 
 
c. General Procedure 2 for preparation of α-chloronitriles. 
To a flame-dried flask was added aldehyde starting material (1 equiv) followed by anhydrous 
Et2O and K2CO3 (0.2 equiv). To this suspension was added TMSCN (1.02 equiv) (Warning: 
acutely toxic, handle with care). Reaction was stirred at room temperature overnight. Reaction 
was then quenched with saturated aqueous NaHCO3 (1 mL/mmol). Layers were separated and 
the aqueous phase was extracted twice with Et2O. Organic layers were combined and 
concentrated. The resulting oil was suspended in 1 N HCl and stirred at rt for 2 hours. The 
reaction was then washed twice with Et2O and the organics were dried over Na2SO4 and 
concentrated to afford the crude cyanohydrin. A new flame-dried flask was charged with a large 
stirbar and cyanuric chloride (1.05 equiv). To this was added DMF (1.1 mL/gram cyanuric 
chloride) and the suspension was stirred vigorously until a white solid was obtained. The solid 
was then suspended by addition of DCM (0.5 M). The crude cyanohydrin was added to the 
reaction as a solution in DCM and stirred at room temperature for 24 hours. The reaction was 
quenched by addition of water and stirred for 10 minutes. Layers were separated and the aqueous 
layer was washed with DCM. Organic phases were combined and washed with saturated 
Na2CO3, then 1 N HCl, then brine. Organics were then dried over Na2SO4 and concentrated to 
afford the crude chloronitrile. Crude oils were purified by column chromatography to afford 
clear oils or white solids. Substrate preparations were unoptimized and the reported reactions 
were performed once. 
 
 
Ethyl 4-chloro-4-cyanobutyrate (1g) 
Prepared from ethyl hemisuccinaldehyde (1.82 g, 14 mmol) following 
General Procedure 2. The crude residue was purified by silica gel 
chromatography (5:95 to 20:80 EtOAc:hexanes) to yield 1.77 g (72% 
yield) of 8g as a clear oil. 1H NMR (500 MHz, Chloroform-d) δ 4.70 (dd, J = 7.5, 6.2 Hz, 1H), 
4.17 (q, J = 7.1 Hz, 2H), 2.73 – 2.53 (m, 2H), 2.49 – 2.28 (m, 2H), 1.28 (t, J = 7.1 Hz, 3H), ; 13C 
NMR (126 MHz, cdcl3) δ 171.34, 116.62, 61.14, 41.50, 31.39, 29.66, 14.15; IR (NaCl/thin film): 
CN
Cl
O
EtO
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2983.27, 2249.74, 1734.19, 1608.59, 1564.56, 1419.07, 1378.34, 1193.90, 1096.48, 1024.20, 
852.08, 795.42, 665.51 cm-1 ; HRMS (MM) calc’d for [M]+ 175.0395, found 175.0380. 
 
tert-Butyl-4-(2-chloro-2-cyanoethyl)piperidine-1-carboxylate (1h) 
Prepared from 2-(1-Boc-4-piperidyl)acetaldehyde (1.0 g, 4.4 mmol) 
following General Procedure 2. The crude residue was purified by silica 
gel chromatography (5:95 to 20:80 EtOAc:hexanes) to yield 837 mg 
(70% yield) of XX as a white solid. 1H NMR (500 MHz, Chloroform-d) δ 4.49 (t, J = 7.6 Hz, 
1H), 4.12 (bs, 2H), 2.71 (bs, 2H), 2.10 – 1.94 (m, 2H), 1.80 (ddd, J = 11.3, 7.6, 4.2 Hz, 1H), 1.72 
– 1.67 (m, 2H), 1.45 (s, 9H), 1.28 – 1.06 (m, 2H); 13C NMR (126 MHz, cdcl3) δ 154.64, 117.08, 
79.61, 43.72, 43.20, 42.63, 40.18, 33.02, 31.44, 31.08, 28.42; IR (NaCl/thin film): 2929.41, 
1673.87, 1417.84, 1246.54, 1161.38, 1127.43, 966.65, 865.88, 769.18, 741.68, 677.80 cm-1; 
HRMS (MM) calc’d for [M+H]+ 273.1364, found 273.1352. 
 
tert-Butyl-4-(chloro(cyano)methyl)piperidine-1-carboxylate (1i) 
Prepared from 1-Boc-piperidine-4-carboxaldehyde (2.0 g, 9.39 mmol) 
following General Procedure 2. The crude residue was purified by silica gel 
chromatography (5:95 to 20:80 EtOAc:hexanes) to yield 570 mg (24% 
yield) of XX as a white solid. 1H NMR (500 MHz, Chloroform-d) δ 4.34 (d, J = 6.1 Hz, 1H), 
4.24 (bs, 2H), 2.70 (bs, 2H), 2.10 – 1.98 (m, 1H), 1.98 – 1.84 (m, 2H), 1.46 (s, m, 11H); 13C 
NMR (126 MHz, cdcl3) δ 154.47, 115.76, 79.95, 47.27, 43.17, 42.70, 41.59, 28.39, 28.35, 27.96; 
IR (NaCl/thin film): 1976.08, 1945.79, 2859.74, 1682.85, 1422.81, 1366.50, 1280.82, 1239.82, 
1166.99, 1128.02, 973.46, 866.39, 760.71 cm-1; HRMS (MM) calc’d for [M+H]+ 259.1208, 
found 259.1256. 
 
2-chloro-2-cyclopropylacetonitrile (11) 
Prepared from cyclopropane carboxaldehyde (1 mL, 13.4 mmol) following General 
Procedure 2. The crude residue was purified by kugelrohr distillation followed by 
silica gel chromatography (100% pentanes) to yield 205 mg (13% yield) of 13 as a clear mobile 
liquid. The product was isolated with some residual pentane due to its volatility. 1H NMR (500 
MHz, Chloroform-d) δ 4.22 (d, J = 7.7 Hz, 1H), 1.53 (qt, J = 7.9, 4.8 Hz, 1H), 0.94 – 0.84 (m, 
BocN
CN
Cl
Cl
CN
BocN Cl
CN
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2H), 0.74 – 0.62 (m, 2H); 13C NMR (126 MHz, cdcl3) δ 115.79, 46.91, 16.59, 6.09, 5.40; IR 
(NaCl/thin film): 3091.35, 3013.92, 2958.47, 2247.22, 1732.61, 1430.84, 1220.80, 1029.90, 
991.98, 926.86, 832.41, 728.05 cm-1; HRMS (MM) calc’d for [M+H]+ 116.0262, found 
116.0258. 
 
3. Cross-Coupling Reactions and Product Characterization 
 
General Procedure 3 for reductive cross-couplings. 
 
A 20 mL scintillation vial was charged with a cross stirbar, Mn0 powder (3 equiv, 33 mg, 0.6 
mmol), aryl iodide (if solid, 1 or 2 equiv, 0.2 or 0.4 mmol), NiCl2(dme) (0.1 equiv, 4.4 mg, 0.02 
mmol), L6 (0.2 equiv, 21.6 mg, 0.04 mmol) and NaBF4 if applicable (1 equiv, 22 mg, 0.2 mmol). 
To this was added 1,4-dioxane (0.68 mL, 0.3M), aryl iodide (if liquid, 1 or 2 equiv, 0.2 or 0.4 
mmol) and TMSCl (0.4 equiv, 33 µL, 0.08 mmol), followed by chloronitrile (1 equiv, 0.2 mmol). 
Reaction was sealed with a Teflon-lined cap and stirred on the benchtop at 500 RPM for 16 
hours. Over this interval reactions turn from dark purple to cloudy red or yellow with significant 
white precipitate. Reactions were diluted with 1 mL of hexane, leading to additional salt 
precipitation. This slurry was loaded directly onto a silica gel or florisil column and eluted in a 
hexane/EtOAc gradient. Excess aryl iodide could be recovered in the first several fractions, with 
cross-coupled product being the most polar component. Reaction success is critically dependent 
on stirring. A stirbar too small for the reaction vessel will fail to suspend the Mn powder and 
lead to low conversions. The reaction vessel should be sufficiently large (solvent height should 
be sufficiently low) to allow even distribution of Mn powder with vigorous stirring. I think we 
should give more detail.  
 
2-(6-chloropyridin-3-yl)-4-phenylbutanenitrile (7a) 
Prepared from 2-chloro-5-iodopyridine (48.0 mg, 0.2 mmol) and 2-
chloro-4-phenylbutanenitrile (36 mg, 0.2 mmol) following General 
Procedure 3. The crude residue was purified by silica gel chromatography 
(0:100 to 10:90 EtOAc:hexanes) to yield 39.8 mg (78% yield) of 7a as a clear oil.  The 
enantiomeric excess was determined to be 85% by chiral SFC analysis (AD, 2.5 mL/min, 8% 
IPA in CO2, λ = 210 nm): tR(minor) = 9.8 min, tR(major) = 13.0 min. 1H NMR (500 MHz, 
N Cl
CN
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Chloroform-d) δ 8.31 (d, J = 2.6 Hz, 1H), 7.66 (dd, J = 8.3, 2.7 Hz, 1H), 7.40 – 7.28 (m, 3H), 
7.28 – 7.22 (m, 1H), 7.22 – 7.17 (m, 2H), 3.77 (dd, J = 9.2, 6.0 Hz, 1H), 2.87 – 2.81 (m, 2H), 
2.34 – 2.27 (m, 1H), 2.16 (dddd, J = 13.7, 8.5, 7.6, 6.0 Hz, 1H).; 13C NMR (126 MHz, cdcl3) δ 
151.54, 148.52, 138.91, 137.56, 130.54, 128.89, 128.40, 126.84, 124.78, 119.22, 37.00, 33.47, 
32.86.; IR (NaCl/thin film): 3027.23, 2926.09, 2242.46, 1586.64, 1566.17, 1496.29, 1460.14, 
1389.42, 1141.53, 1108.27, 1022.71, 832.61, 741. 61, 700.19 cm-1; [α]D25 = -12.081 (c = 1.410, 
CHCl3). HRMS (MM) calc’d for [M+Na]+ 279.0659, found 279.0702. 
 
2-(6-bromopyridin-3-yl)-4-phenylbutanenitrile (7b) 
Prepared from 2-bromo-5-iodopyridine (56.8 mg, 0.2 mmol) and 2-
chloro-4-phenylbutanenitrile (36 mg, 0.2 mmol) with NaBF4 (22 mg, 0.2 
mmol) following General Procedure 3. The crude residue was purified by 
silica gel chromatography (0:100 to 10:90 EtOAc:hexanes) to yield 40.9 mg (68% yield) of 7b as 
a clear oil.  The enantiomeric excess was determined to be 88% by chiral SFC analysis (AD, 2.5 
mL/min, 10% IPA in CO2, λ = 280 nm): tR(minor) = 9.5 min, tR(major) = 12.2 min.  1H NMR 
(500 MHz, Chloroform-d) δ 8.29 (dt, J = 2.5, 0.6 Hz, 1H), 7.54 (qd, J = 8.3, 1.7 Hz, 2H), 7.42 – 
7.29 (m, 2H), 7.29 – 7.22 (m, 1H), 7.22 – 7.14 (m, 2H), 3.74 (dd, J = 9.2, 6.0 Hz, 1H), 2.90 – 
2.78 (m, 2H), 2.29 (dddd, J = 13.9, 9.3, 8.0, 6.0 Hz, 1H), 2.16 (dddd, J = 13.7, 8.5, 7.6, 6.0 Hz, 
1H); 13C NMR (126 MHz, cdcl3) δ 148.97, 142.08, 138.88, 137.29, 130.97, 128.89, 128.57, 
128.40, 126.85, 119.13, 36.95, 33.53, 32.85; IR (NaCl/thin film): 3026.73, 2925.74, 2859.37, 
2242.11, 1734.00, 1581.13, 1561.56, 1496.15, 1455.35, 1385.97, 1090.22, 1019.79, 830.73, 
735.64, 699.99 cm-1; [α]D25 = -4.695 (c = 1.180, CHCl3). HRMS (MM) calc’d for [M+H]+ 
301.0335, found 301.0341. 
 
4-phenyl-2-(6-(trifluoromethyl)pyridin-3-yl)butanenitrile (7c) 
Prepared from 5-iodo-2-trifluoromethylpyridine (54.6 mg, 0.2 mmol) 
and 2-chloro-4-phenylbutanenitrile (36 mg, 0.2 mmol) with NaBF4 (22 
mg, 0.2 mmol) following General Procedure 3. The crude residue was 
purified by silica gel chromatography (0:100 to 10:90 EtOAc:hexanes) to yield 39.7 mg (68% 
yield) of 7c as a clear oil.  The enantiomeric excess was determined to be 85% by chiral SFC 
analysis (AD, 2.5 mL/min, 7% IPA in CO2, λ = 254 nm): tR(minor) = 3.0 min, tR(major) = 4.7 
N Br
CN
N CF3
CN
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min.  1H NMR (500 MHz, Chloroform-d) δ 8.64 (d, J = 2.2 Hz, 1H), 7.89 (dd, J = 8.1, 2.3 Hz, 
1H), 7.73 (dd, J = 8.2, 0.8 Hz, 1H), 7.40 – 7.29 (m, 2H), 7.29 – 7.22 (m, 1H), 7.22 – 7.14 (m, 
2H), 3.87 (dd, J = 9.3, 5.9 Hz, 1H), 2.93 – 2.82 (m, 2H), 2.39 – 2.28 (m, 1H), 2.21 (dddd, J = 
13.7, 8.5, 7.7, 5.9 Hz, 1H); 13C NMR (126 MHz, cdcl3) δ 148.93, δ 148.18 (q, JC-F = 35.3 Hz), 
138.77, 136.28, 134.83, 128.92, 128.40, 128.38, 126.91, 126.89, 120.81 (q, JC-F = 2.7 Hz), 
118.87, 37.02, 34.03, 32.90.; IR (NaCl/thin film): 3028.51, 2928.97, 2862.95, 2243.85, 1735.25, 
1602.71, 1496.75, 1454.95, 1403.90, 1339.65, 1178.34, 1137.96, 1088.63, 1027.88, 850.30, 
751.10, 700.69 cm-1; [α]D25 = -21.304 (c = 1.475, CHCl3). HRMS (MM) calc’d for [M+H]+ 
291.1104, found 291.1181. 
 
2-(6-methoxypyridin-3-yl)-4-phenylbutanenitrile (7d) 
Prepared from 5-iodo-2-methoxypyridine (94.0 mg, 0.4 mmol) and 2-
chloro-4-phenylbutanenitrile (36 mg, 0.2 mmol) with NaBF4 (22 mg, 
0.2 mmol) following General Procedure 3. The crude residue was 
purified by silica gel chromatography (0:100 to 20:80 EtOAc:hexanes) to yield 22.8 mg (45% 
yield) of 7d as a clear oil.  The enantiomeric excess was determined to be 83% by chiral SFC 
analysis (AD, 2.5 mL/min, 8% IPA in CO2, λ = 245 nm): tR(minor) = 6.5 min, tR(major) = 7.5 
min.  1H NMR (500 MHz, Chloroform-d) δ 8.07 (dt, J = 2.6, 0.6 Hz, 1H), 7.55 (ddd, J = 8.6, 2.6, 
0.4 Hz, 1H), 7.37 – 7.28 (m, 2H), 7.26 – 7.21 (m, 1H), 7.21 – 7.17 (m, 2H), 6.78 (dd, J = 8.6, 0.7 
Hz, 1H), 3.94 (s, 3H), 3.69 (dd, J = 8.8, 6.3 Hz, 1H), 2.81 (td, J = 8.1, 3.5 Hz, 2H), 2.35 – 2.21 
(m, 1H), 2.14 (dddd, J = 13.8, 8.5, 7.5, 6.4 Hz, 1H).; 13C NMR (126 MHz, cdcl3) δ 164.04, 
145.68, 139.41, 137.39, 128.77, 128.42, 126.64, 124.09, 120.16, 111.56, 53.67, 37.04, 33.28, 
32.85.; IR (NaCl/thin film): 2925.19, 1849.43, 2240.05, 1608.56, 1572.83, 1494.73, 1395.28, 
1290.62, 1024.55, 831.08, 750.29, 699.95 cm-1; [α]D25 = -9.806 (c = 0.790, CHCl3). HRMS 
(MM) calc’d for [M+Na]+ 275.1155, found 275.1175. 
 
2-(6-fluoropyridin-3-yl)-4-phenylbutanenitrile (7e) 
Prepared from 2-fluoro-5-iodopyridine (89.2 mg, 0.4 mmol) and 2-chloro-
4-phenylbutanenitrile (36 mg, 0.2 mmol) following General Procedure 3. 
The crude residue was purified by silica gel chromatography (0:100 to 
10:90 EtOAc:hexanes) to yield 30.7 mg (64% yield) of 7e as a clear oil.  The enantiomeric 
N OMe
CN
N F
CN
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excess was determined to be 87% by chiral SFC analysis (AD, 2.5 mL/min, 8% IPA in CO2, λ = 
254 nm): tR(minor) = 5.2 min, tR(major) = 6.4 min.  1H NMR (500 MHz, Chloroform-d) δ 8.18 – 
8.10 (m, 1H), 7.79 (ddd, J = 8.5, 7.2, 2.7 Hz, 1H), 7.38 – 7.28 (m, 2H), 7.28 – 7.22 (m, 1H), 7.22 
– 7.16 (m, 2H), 6.99 (ddd, J = 8.5, 3.1, 0.6 Hz, 1H), 3.78 (dd, J = 9.2, 6.0 Hz, 1H), 2.93 – 2.77 
(m, 2H), 2.31 (dddd, J = 14.0, 9.3, 8.1, 6.0 Hz, 1H), 2.17 (dddd, J = 13.7, 8.5, 7.6, 6.0 Hz, 1H); 
13C NMR (126 MHz, cdcl3) δ 163.33 (d, JC-F = 241.3 Hz), 146.57 (d, JC-F = 15.3 Hz), 140.02 (d, 
JC-F = 8.2 Hz), 138.98, 129.33 (d, JC-F = 4.7 Hz), 128.87, 128.40, 126.82, 119.45, 110.26 (d, JC-F 
= 37.6 Hz), 37.11, 33.29 (d, JC-F = 1.6 Hz), 32.88. ; IR (NaCl/thin film): 3027.76, 2926.65, 
2859.25, 2242.02, 1599.81, 1484.95, 1399.59, 1256.76, 1127.35, 1025.00, 831.20, 748.87, 
700.31 cm-1; [α]D25 = -27.336 (c = 1.155, CHCl3). HRMS (MM) calc’d for [M+H]+ 241.1136, 
found 241.1210. 
 
2-(2-fluoropyridin-4-yl)-4-phenylbutanenitrile (7f) 
Prepared from 2-fluoro-4-iodopyridine (44.6 mg, 0.2 mmol) and 2-chloro-
4-phenylbutanenitrile (36 mg, 0.2 mmol) with NaBF4 (22 mg, 0.2 mmol) 
following General Procedure 3. The crude residue was purified by silica 
gel chromatography (0:100 to 10:90 EtOAc:hexanes) to yield 28.8 mg (60% yield) of 7f as a 
clear oil.  The enantiomeric excess was determined to be 79% by chiral SFC analysis (AD, 2.5 
mL/min, 8% IPA in CO2, λ = 210 nm): tR(minor) = 4.7 min, tR(major) = 5.5 min.  1H NMR (500 
MHz, Chloroform-d) δ 8.25 (d, J = 5.2 Hz, 1H), 7.36 – 7.31 (m, 2H), 7.29 – 7.23 (m, 1H), 7.22 – 
7.18 (m, 2H), 7.17 – 7.14 (m, 1H), 6.92 (td, J = 1.5, 0.7 Hz, 1H), 3.79 (dd, J = 9.4, 5.6 Hz, 1H), 
2.92 – 2.83 (m, 2H), 2.29 (dddd, J = 13.7, 9.5, 8.2, 5.5 Hz, 1H), 2.23 – 2.15 (m, 1H).; 13C NMR 
(126 MHz, cdcl3) δ 164.13 (d, JC-F = 240.5 Hz), 163.17, 150.09, 148.71 (d, JC-F = 15.3 Hz), 
138.83, 128.91, 128.39, 126.90, 120.00 (d, JC-F = 4.4 Hz), 118.59, 108.40 (d, JC-F = 38.8 Hz), 
36.61, 35.85 (d, JC-F = 3.3 Hz), 32.90. ; IR (NaCl/thin film): 2923.87, 2851.17, 2244.02, 1734.43, 
1611.28, 1569.24, 1454.61, 1414.02, 1277.86, 839.28, 751.37, 700.44  cm-1; [α]D25 = -22.036 (c 
= 0.45, CHCl3). HRMS (MM) calc’d for [M+H]+ 241.1136, found 241.1134. 
 
2-(2-fluoropyridin-3-yl)-4-phenylbutanenitrile (7g) 
Prepared from 2-fluoro-3-iodopyridine (44.6 mg, 0.2 mmol) and 2-chloro-4-
phenylbutanenitrile (36 mg, 0.2 mmol) following General Procedure 3. The 
N
CN
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CN
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crude residue was purified by silica gel chromatography (0:100 to 10:90 EtOAc:hexanes) to 
yield 16.7 mg (35% yield) of 7g as a clear oil.  The enantiomeric excess was determined to be 
83% by chiral SFC analysis (AD, 2.5 mL/min, 6% IPA in CO2, λ = 245 nm): tR(minor) = 4.9 
min, tR(major) = 5.8 min.  1H NMR (500 MHz, Chloroform-d) δ 8.21 (ddd, J = 4.9, 1.9, 1.2 Hz, 
1H), 7.98 – 7.87 (m, 1H), 7.35 – 7.29 (m, 2H), 7.29 – 7.22 (m, 2H), 7.22 – 7.18 (m, 2H), 4.03 (t, 
J = 7.4 Hz, 1H), 2.94 – 2.80 (m, 2H), 2.30 – 2.18 (m, 2H); 13C NMR (126 MHz, cdcl3) δ 160.30 
(d, JC-F = 239.3 Hz), 147.65 (d, JC-F = 14.8 Hz), 139.59 (d, JC-F = 4.3 Hz), 139.02, 128.78, 
128.37, 126.74, 122.09 (d, JC-F = 4.3 Hz), 118.80, 118.23 (d, JC-F = 29.6 Hz), 35.26, 33.06, 30.83 
(d, JC-F = 2.5 Hz); IR (NaCl/thin film): 2925.09, 2853.97, 2244.15, 1734.36, 1606.84, 1577.55, 
1441.07, 1248.36, 1101.26, 805.44, 750.96, 699.91 cm-1; [α]D25 = -29.296 (c = 0.635, CHCl3). 
HRMS (MM) calc’d for [M+H]+ 241.1136, found 241.1133. 
 
2-(2-chloropyrimidin-5-yl)-4-phenylbutanenitrile (7h) 
Prepared from 2-chloro-5-iodopyrimidine (48.1 mg, 0.2 mmol) and 2-
chloro-4-phenylbutanenitrile (36 mg, 0.2 mmol) following General 
Procedure 3. The crude residue was purified by flash column 
chromatography using Florisil® stationary phase (0:100 to 15:85 EtOAc:hexanes) to yield 21.2 
mg (41% yield) of 7h as a clear oil.  The enantiomeric excess was determined to be 89% by 
chiral SFC analysis (AD, 2.5 mL/min, 10% IPA in CO2, λ = 210 nm): tR(minor) = 6.2 min, 
tR(major) = 7.0 min.  1H NMR (500 MHz, Chloroform-d) δ 8.59 (d, J = 0.5 Hz, 2H), 7.37 – 7.31 
(m, 2H), 7.30 – 7.24 (m, 1H), 7.22 – 7.17 (m, 2H), 3.78 (dd, J = 9.4, 5.9 Hz, 1H), 2.95 – 2.84 (m, 
2H), 2.34 (dddd, J = 13.6, 9.4, 7.7, 5.8 Hz, 1H), 2.19 (dtd, J = 13.8, 8.0, 5.9 Hz, 1H); 13C NMR 
(126 MHz, cdcl3) δ 161.50, 158.30, 138.35, 129.03, 128.39, 128.36, 127.07, 118.06, 36.65, 
32.80, 31.36; IR (NaCl/thin film): 2923.61, 2850.58, 2243.80, 1735.29, 1580.36, 1550.38, 
1401.12, 1160.95, 772.57, 748.86, 700.55, 640.20 cm-1; [α]D25 = -14.892 (c = 0.305, CHCl3). 
HRMS (MM) calc’d for [M+H]+ 258.0793, found 258.0257. 
 
2-(2-methoxypyrimidin-5-yl)-4-phenylbutanenitrile (7i) 
Prepared from 5-iodo-2-methoxypyrimidine (89.2 mg, 0.4 mmol) and 2-
chloro-4-phenylbutanenitrile (36 mg, 0.2 mmol) with NaBF4 (22 mg, 
0.2 mmol) following General Procedure 3. The crude residue was 
N
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purified by florisil gel chromatography (0:100 to 40:60 EtOAc:hexanes) to yield 35.8 mg (71% 
yield) of 7i as a clear oil.  The enantiomeric excess was determined to be 92% by chiral SFC 
analysis (AS, 2.5 mL/min, 10% IPA in CO2, λ = 254 nm): tR(minor) = 4.5 min, tR(major) = 5.0 
min.  1H NMR (500 MHz, Chloroform-d) δ 8.47 (d, J = 0.4 Hz, 2H), 7.38 – 7.29 (m, 2H), 7.28 – 
7.23 (m, 1H), 7.22 – 7.17 (m, 2H), 4.04 (s, 3H), 3.71 (dd, J = 9.1, 6.1 Hz, 1H), 2.89 – 2.82 (m, 
2H), 2.31 (dddd, J = 13.9, 9.2, 7.9, 6.1 Hz, 1H), 2.16 (dddd, J = 13.7, 8.4, 7.6, 6.1 Hz, 1H); 13C 
NMR (126 MHz, cdcl3) δ 165.54, 158.16, 138.84, 128.91, 128.40, 126.86, 122.72, 119.06, 55.30, 
36.79, 32.79, 31.17; IR (NaCl/thin film): 3026.71, 2928.66, 2241.18, 1600.01, 1560.30, 1474.60, 
1410.27, 1331.54, 1031.65, 803.93, 700.50 cm-1; [α]D25 = -17.013 (c = 0.395, CHCl3). HRMS 
(MM) calc’d for [M+H]+ 254.1288, found 254.1310. 
 
4-phenyl-2-(2-phenylthio)pyrimidin-5-yl)butanenitrile (7j) 
Prepared from 5-iodo-2-phenylthiopyrimidine (62.8 mg, 0.2 mmol) and 
2-chloro-4-phenylbutanenitrile (36 mg, 0.2 mmol) following General 
Procedure 3. The crude residue was purified by silica gel 
chromatography (0:100 to 30:70 EtOAc:hexanes) to yield 50.3 mg (76% yield) of 7j as a clear 
oil.  The enantiomeric excess was determined to be 91% by chiral SFC analysis (AD, 2.5 
mL/min, 15% IPA in CO2, λ = 280 nm): tR(minor) = 11.3 min, tR(major) = 12.7 min.  1H NMR 
(500 MHz, Chloroform-d) δ 8.44 (s, 2H), 7.70 – 7.56 (m, 2H), 7.50 – 7.40 (m, 3H), 7.37 – 7.29 
(m, 2H), 7.28 – 7.22 (m, 1H), 7.20 – 7.14 (m, 2H), 3.67 (dd, J = 9.0, 6.0 Hz, 1H), 2.89 – 2.79 (m, 
2H), 2.28 (dddd, J = 13.9, 9.2, 7.9, 6.1 Hz, 1H), 2.13 (dddd, J = 13.7, 8.4, 7.7, 6.1 Hz, 1H); 13C 
NMR (126 MHz, cdcl3) δ 173.10, 156.34, 138.73, 135.37, 129.65, 129.37, 128.92, 128.80, 
128.38, 126.89, 124.93, 118.64, 36.64, 32.74, 31.50; IR (NaCl/thin film): 3025.13, 2926.01, 
2242,07, 1734.06, 1580.58, 1539.37, 1399.77, 1170.57, 748.46, 701.21, 689.27 cm-1; [α]D25 = 
+10.214 (c = 1.965, CHCl3). HRMS (MM) calc’d for [M+H]+ 332.1216, found 332.1746. 
 
4-phenyl-2-(2-(piperidin-1-yl)pyrimidin-5-yl)butanenitrile (7k) 
Prepared from 5-iodo-2-(piperidin-1-yl)pyrimidine (57.8 mg, 0.2 
mmol) and 2-chloro-4-phenylbutanenitrile (36.0 mg, 0.2 mmol) 
following General Procedure 3. The crude residue was purified by 
silica gel chromatography (0:100 to 40:60 EtOAc:hexanes) to yield 
43.1 mg (70% yield) of 7k as a white solid.  The enantiomeric excess was determined to be 85% 
N
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by chiral SFC analysis (AD, 2.5 mL/min, 15% IPA in CO2, λ = 254 nm): tR(minor) = 7.5 min, 
tR(major) = 8.6 min. The product could be further enriched via recrystallization by vapor 
diffusion of pentane to a saturated solution of 7k in DCM, affording 38.4 mg (89% recovery) of 
white needles. The enantiomeric excess of recrystallized 7k was determined to be 95%.  1H 
NMR (500 MHz, Chloroform-d) δ 8.22 (s, 2H), 7.35 – 7.29 (m, 2H), 7.26 – 7.21 (m, 1H), 7.21 – 
7.16 (m, 2H), 3.93 – 3.70 (m, 4H), 3.55 (dd, J = 8.6, 6.5 Hz, 1H), 2.81 (td, J = 8.0, 7.3, 2.1 Hz, 
2H), 2.25 (dddd, J = 13.6, 8.6, 7.9, 6.5 Hz, 1H), 2.11 (dddd, J = 13.7, 8.3, 7.4, 6.5 Hz, 1H), 1.76 
– 1.65 (m, 2H), 1.65 – 1.54 (m, 4H); 13C NMR (126 MHz, cdcl3) δ 161.27, 156.64, 139.33, 
128.78, 128.42, 126.64, 119.91, 115.78, 44.89, 36.74, 32.73, 31.18, 25.71, 24.78.; IR (NaCl/thin 
film): 2932.29, 2853.60, 2239.17, 1605.13, 1514.57, 1448.02, 1364.20, 1271.93, 1024.80, 
947.51, 797.14, 700.19 cm-1; [α]D25 = +13.073 (c = 1.595, CHCl3). HRMS (MM) calc’d for 
[M+H]+ 307.1917, found 307.1848. 
 
4-phenyl-2-(2-(pyrrolidin-1-yl)pyrimidin-5-yl)butanenitrile (7l) 
Prepared from 5-iodo-2-(pyrrolidin-1-yl)pyrimidine (55 mg, 0.2 
mmol) and 2-chloro-4-phenylbutanenitrile (36.0 mg, 0.2 mmol) 
following General Procedure 3. The crude residue was purified by 
silica gel chromatography (0:100 to 40:60 EtOAc:hexanes) to yield 
35.0 mg (60% yield) of 7l as a white solid.  The enantiomeric excess was determined to be 85% 
by chiral SFC analysis (AD, 2.5 mL/min, 12% IPA in CO2, λ = 235 nm): tR(minor) = 10.8 min, 
tR(major) = 12.5 min. The product could be further enriched via recrystallization by vapor 
diffusion of pentane to a saturated solution of 7l in DCM, affording 31.8 mg (91% recovery) of 
white needles. The enantiomeric excess of recrystallized 7l was determined to be 97%.    1H 
NMR (500 MHz, Chloroform-d) δ 8.25 (s, 2H), 7.34 – 7.29 (m, 2H), 7.26 – 7.21 (m, 1H), 7.21 – 
7.16 (m, 2H), 3.66 – 3.49 (m, 5H), 2.81 (t, J = 7.6 Hz, 2H), 2.26 (ddt, J = 13.7, 8.5, 7.2 Hz, 1H), 
2.11 (dtd, J = 13.6, 7.8, 6.6 Hz, 1H), 2.05 – 1.96 (m, 4H).; 13C NMR (126 MHz, cdcl3) δ 156.64, 
139.30, 128.79, 128.42, 126.65, 121.43, 119.93, 115.75, 46.78, 36.76, 32.72, 31.22, 25.52; IR 
(NaCl/thin film): 2927.97, 2866.57, 2238.90, 1603.00, 1524.42, 1483.96, 1460.18, 1335.03, 798. 
26, 699.99 cm-1; [α]D25 = +12.942 (c = 1.130, CHCl3). HRMS (MM) calc’d for [M+H3O]+ 
311.1826, found 311.1825. 
 
tert-butyl-4-(5-(1-cyano-3-phenylpropyl)pyrimidin-2-yl)piperazine-1-carboxylate (7m) 
N
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Prepared from 5-iodo-2-(4-Boc-piperazin-1-yl)pyrimidine (78.0 
mg, 0.2 mmol) and 2-chloro-4-phenylbutanenitrile (36.0 mg, 0.2 
mmol) following General Procedure 3. The crude residue was 
purified by silica gel chromatography (0:100 to 40:60 
EtOAc:hexanes) to yield 56.5 mg (69% yield) of 7m as a white solid.  The enantiomeric excess 
was determined to be 85% by chiral SFC analysis (AD, 2.5 mL/min, 15% IPA in CO2, λ = 235 
nm): tR(minor) = 7.5 min, tR(major) = 9.0 min. The product could be further enriched via 
recrystallization by vapor diffusion of pentane to a saturated solution of 7m in benzene, 
affording 51.0 mg (90% recovery) of white needles. The enantiomeric excess of recrystallized 
7m was determined to be 94%. 1H NMR (500 MHz, Chloroform-d) δ 8.25 (s, 2H), 7.37 – 7.27 
(m, 2H), 7.25 – 7.20 (m, 1H), 7.20 – 7.15 (m, 2H), 3.83 – 3.79 (m, 4H), 3.58 (dd, J = 8.7, 6.4 Hz, 
1H), 3.50 (t, J = 5.3 Hz, 4H), 2.90 – 2.73 (m, 2H), 2.26 (dddd, J = 13.6, 8.7, 7.2, 4.1 Hz, 1H), 
2.11 (dddd, J = 13.7, 8.4, 7.5, 6.4 Hz, 1H), 1.49 (s, 9H); 13C NMR (126 MHz, cdcl3) δ 161.27, 
156.70, 154.78, 139.21, 128.81, 128.40, 126.69, 119.71, 117.11, 80.07, 43.65, 42.86 (br), 36.74, 
32.74, 31.18, 28.43; IR (NaCl/thin film): 2977.91, 2927.86, 2861.14, 2243.21, 1687.28, 1607.00, 
1517.48, 1496.25, 1424.34, 1364.59, 1247.24, 1176.22, 1129.18, 999.26, 793.95, 696.53 cm-1; 
[α]D25 = +13.500 (c = 1.980, CHCl3). HRMS (MM) calc’d for [M+Na]+ 430.2213, found 
430.2294. 
 
4-phenyl-2-(thiophen-2-yl)butanenitrile (7n) 
Prepared from 2-iodothiophene (111 µL, 1.0 mmol)  and 2-chloro-4-
phenylbutanenitrile (180 mg, 1.0 mmol) following General Procedure 3. The 
crude residue was purified by silica gel chromatography (0:100 to 10:90 
EtOAc:hexanes) to yield 170 mg (75% yield) of 7n as a clear oil.  The enantiomeric excess was 
determined to be 88% by chiral SFC analysis (AD, 2.5 mL/min, 8% IPA in CO2, λ = 245 nm): 
tR(minor) = 5.8 min, tR(major) = 7.1 min.  1H NMR (500 MHz, Chloroform-d) δ 7.36 – 7.31 (m, 
2H), 7.29 (dd, J = 5.1, 1.3 Hz, 1H), 7.27 – 7.23 (m, 1H), 7.22 (dq, J = 7.6, 0.7 Hz, 2H), 7.08 (dt, 
J = 3.5, 1.0 Hz, 1H), 7.00 (dd, J = 5.1, 3.5 Hz, 1H), 4.03 (ddd, J = 8.6, 6.3, 0.8 Hz, 1H), 2.94 – 
2.82 (m, 2H), 2.41 – 2.24 (m, 2H); 13C NMR (126 MHz, cdcl3) δ 139.49, 137.62, 128.76, 128.50, 
127.13, 126.62, 126.31, 125.61, 119.74, 37.32, 32.85, 31.66; IR (NaCl/thin film): 3085.49, 
3062.55, 3026.78, 2927.12, 2860.88, 2241.68, 1602.83, 1496.13, 1454.38, 1238.04, 1080.89, 
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1029.74, 833.92, 750.39, 699.80 cm-1; [α]D25 = -27.559 (c = 1.455, CHCl3). HRMS (MM) calc’d 
for [M+H3O]+ 246.0947, found 246.1107. 
 
2-(2-(4-bromophenyl)imidazo[1,2-a]pyridin-6-yl)-4-phenylbutanenitrile (7o) 
Prepared from 2-(4-bromophenyl)-6-iodoimidazo[1,2-
a]pyridine (159.6 mg, 0.4 mmol) and 2-chloro-4-
phenylbutanenitrile (36.0 mg, 0.2 mmol) following General 
Procedure 3. The crude residue was purified by silica gel chromatography (5:95 to 20:80 
acetone:hexanes) to yield 60.0 mg (72% yield) of 7o as a white solid.  The enantiomeric excess 
was determined to be 87% by chiral SFC analysis (IA, 2.5 mL/min, 40% IPA in CO2, λ = 245 
nm): tR(minor) = 10.7 min, tR(major) = 14.3 min. The product could be further enriched via 
recrystallization by vapor diffusion of pentane to a saturated solution of 7o in DCM, affording 
52.2 mg (87% recovery) of white needles. The enantiomeric excess of recrystallized 7o was 
determined to be 97%.  Following column chromatography, a UV active peak remained in the 
SFC trace (tR = 8.6 min) that was not observed in any other analysis. This peak was significantly 
diminished following recrystallization.   1H NMR (500 MHz, Chloroform-d) δ 8.19 – 8.11 (m, 
1H), 7.86 (d, J = 0.7 Hz, 1H), 7.85 – 7.78 (m, 2H), 7.64 (d, J = 9.4 Hz, 1H), 7.60 – 7.53 (m, 2H), 
7.38 – 7.30 (m, 2H), 7.28 – 7.23 (m, 1H), 7.21 (dq, J = 7.7, 0.7 Hz, 2H), 7.07 (dd, J = 9.3, 1.9 
Hz, 1H), 3.77 (dd, J = 9.0, 5.7 Hz, 1H), 2.93 – 2.83 (m, 2H), 2.33 (dddd, J = 13.8, 9.1, 8.2, 5.7 
Hz, 1H), 2.25 (dddd, J = 13.7, 8.5, 7.7, 5.8 Hz, 1H); 13C NMR (126 MHz, cdcl3) δ 145.73, 
144.82, 139.13, 132.34, 131.93, 128.86, 128.41, 127.59, 126.80, 124.07, 123.75, 122.23, 121.06, 
119.44, 118.31, 108.76, 36.51, 33.80, 32.88; IR (NaCl/thin film): 2924.20, 2854.07, 2240.70, 
1472.83, 1435.81, 1354.99, 1208.78, 1067.55, 1009.04, 833.96, 806.47, 738.54, 700.04 cm-1; 
[α]D25 = +28.004 (c = 0.275, CHCl3). HRMS (MM) calc’d for [M+H]+ 416.0757, found 
416.0698. 
 
4-phenyl-2-(quinolin-3-yl)butanenitrile (3a) 
Prepared from 3-iodoquinoline (51.2 mg, 0.2 mmol) and 2-chloro-4-
phenylbutanenitrile (36.0 mg, 0.2 mmol) with NaBF4 (22.0 mg, 0.2 
mmol) following General Procedure 3. The crude residue was purified 
by silica gel chromatography (0:100 to 40:60 EtOAc:hexanes) to yield 39.4 mg (72% yield) of 
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3a as a light yellow oil that solidified on standing.  The enantiomeric excess was determined to 
be 92% by chiral SFC analysis (AD, 2.5 mL/min, 20% IPA in CO2, λ = 280 nm): tR(major) = 6.1 
min, tR(minor) = 6.8 min.  1H NMR (500 MHz, Chloroform-d) δ 8.81 (s, 1H), 8.18 (d, J = 2.3 
Hz, 1H), 8.12 (d, J = 8.4 Hz, 1H), 7.85 (dd, J = 8.2, 1.3 Hz, 1H), 7.76 (ddd, J = 8.4, 6.9, 1.5 Hz, 
1H), 7.61 (ddd, J = 8.1, 6.8, 1.1 Hz, 1H), 7.38 – 7.28 (m, 2H), 7.28 – 7.15 (m, 3H), 3.99 (dd, J = 
9.0, 5.9 Hz, 1H), 2.95 – 2.82 (m, 2H), 2.39 (dddd, J = 14.0, 9.2, 7.9, 6.2 Hz, 1H), 2.30 (dddd, J = 
13.7, 8.5, 7.7, 5.9 Hz, 1H); 13C NMR (126 MHz, cdcl3) δ 149.22, 147.75, 139.21, 134.28, 
130.18, 129.42, 128.85, 128.57, 128.45, 127.78, 127.62, 127.56, 126.76, 119.74, 37.18, 34.39, 
32.99; IR (NaCl/thin film): 3026.11, 2926.11, 2241.03, 1603.40, 1571.03, 1495.05, 1454.48, 
1125.63, 906.13, 787.96, 751.66, 700.17 cm-1; [α]D25 = -1.617 (c = 0.952, CHCl3). HRMS (MM) 
calc’d for [M+H]+ 273.1386, found 273.1589. 
 
2-(quinolin-3-yl)propanenitrile (3b) 
Prepared from 3-iodoquinoline (51.2 mg, 0.2 mmol) and 2-chloropropanenitrile 
(17 µL, 0.2 mmol) following General Procedure 3. The crude residue was 
purified by silica gel chromatography (0:100 to 20:80 EtOAc:hexanes) to yield 
28.7 mg (79% yield) of 3b as a clear oil.  The enantiomeric excess was determined to be 81% by 
chiral SFC analysis (AD, 2.5 mL/min, 10% IPA in CO2, λ = 254 nm): tR(major) = 7.8 min, 
tR(minor) = 8.8 min.  1H NMR (300 MHz, Chloroform-d) δ 8.87 (d, J = 2.4 Hz, 1H), 8.23 (d, J = 
2.4 Hz, 1H), 8.14 (d, J = 8.5 Hz, 1H), 7.92 – 7.84 (m, 1H), 7.77 (ddd, J = 8.4, 6.9, 1.5 Hz, 1H), 
7.62 (ddd, J = 8.2, 6.9, 1.2 Hz, 1H), 4.16 (q, J = 7.3 Hz, 1H), 1.78 (dd, J = 7.3, 0.5 Hz, 3H); 13C 
NMR (126 MHz, cdcl3) δ 149.01, 147.67, 133.57, 130.13, 129.83, 129.34, 127.78, 127.58, 
127.54, 120.60, 29.26, 21.39; IR (NaCl/thin film): 2924.03, 2850.94, 2241.83, 1570.25, 1496.55, 
1457.22, 1378.86, 1126.13, 1082.83, 966.72, 907.45, 787.48, 752.77, 617.35 cm-1; [α]D25 = -
20.200 (c = .355, CHCl3). HRMS (MM) calc’d for [M+H3O]+ 201.1022, found 201.1022. 
 
4-methyl-2-(quinolin-3-yl)pentanenitrile (3c) 
Prepared from 3-iodoquinoline (51.2 mg, 0.2 mmol) and 2-chloro-4-
methylpentanenitrile (26.2 mg, 0.2 mmol) following General Procedure 3. 
The crude residue was purified by silica gel chromatography (0:100 to 
30:70 EtOAc:hexanes) to yield 29.1 mg (65% yield) of 3c as a clear oil.  The enantiomeric 
N
CN
Me
N
CN
Me
Me
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excess was determined to be 89% by chiral SFC analysis (OB-H, 2.5 mL/min, 5% IPA in CO2, λ 
= 254 nm): tR(minor) = 4.2 min, tR(major) = 4.6 min.  1H NMR (500 MHz, Chloroform-d) δ 8.83 
(d, J = 2.4 Hz, 1H), 8.19 (d, J = 2.4 Hz, 1H), 8.13 (dq, J = 8.5, 0.9 Hz, 1H), 7.85 (ddd, J = 8.1, 
1.3, 0.7 Hz, 1H), 7.76 (ddd, J = 8.5, 6.9, 1.4 Hz, 1H), 7.61 (ddd, J = 8.1, 6.9, 1.2 Hz, 1H), 4.05 
(dd, J = 9.8, 6.2 Hz, 1H), 2.06 – 1.97 (m, 1H), 1.96 – 1.86 (m, 1H), 1.75 (ddd, J = 13.5, 8.6, 6.2 
Hz, 1H), 1.04 (dd, J = 11.3, 6.6 Hz, 6H); 13C NMR (126 MHz, cdcl3) δ 149.31, 147.66, 134.09, 
130.08, 129.34, 129.21, 127.73, 127.63, 127.50, 120.06, 44.85, 33.43, 26.23, 22.59, 21.58; IR 
(NaCl/thin film): 2957.60, 2928.61, 2238.86, 1653.55, 1570.26, 1494.77, 1467.80, 1369.63, 
1280.03, 1116.26, 787.30, 752.79 cm-1; [α]D25 = -22.811 (c = 0.350, CHCl3). HRMS (MM) 
calc’d for [M+H3O]+ 243.1492, found 243.1194. 
 
4,4-dimethyl-2-(quinolin-3-yl)pentanenitrile (3d) 
Prepared from 3-iodoquinoline (51.2 mg, 0.2 mmol)  and 2-chloro-4,4-
dimethylpentanenitrile (29.1 mg, 0.2 mmol) following General Procedure 3. 
The crude residue was purified by silica gel chromatography (0:100 to 30:70 
EtOAc:hexanes) to yield 21.4 mg (45% yield) of 3d as a clear oil.  The enantiomeric excess was 
determined to be 93% by chiral SFC analysis (AD, 2.5 mL/min, 12% IPA in CO2, λ = 280 nm): 
tR(major) = 5.5 min, tR(minor) = 6.8 min.  1H NMR (500 MHz, Chloroform-d) δ 8.81 (d, J = 2.4 
Hz, 1H), 8.20 (d, J = 2.4 Hz, 1H), 8.12 (dd, J = 8.5, 1.0 Hz, 1H), 7.84 (ddt, J = 8.1, 1.3, 0.6 Hz, 
1H), 7.75 (ddd, J = 8.4, 6.9, 1.5 Hz, 1H), 7.60 (ddd, J = 8.1, 6.9, 1.2 Hz, 1H), 4.00 (dd, J = 10.3, 
3.4 Hz, 1H), 2.15 (dd, J = 14.2, 10.4 Hz, 1H), 1.76 (dd, J = 14.2, 3.4 Hz, 1H), 1.12 (s, 9H); 13C 
NMR (126 MHz, cdcl3) δ 149.40, 147.52, 133.87, 130.57, 130.04, 129.32, 127.73, 127.61, 
127.50, 121.19, 50.25, 31.37, 31.16, 29.40. IR (NaCl/thin film): 2956.95, 2239.66, 1734.18, 
1495.05, 1477.11, 1280.54, 1116.30, 1012.66, 897.41, 788.79, 752.85, 619.63 cm-1; [α]D25 = -
55.546 (c = 0.515, CHCl3). HRMS (MM) calc’d for [M+H]+ 239.1543, found 239.1530. 
 
3-phenyl-2-(quinolin-3-yl)propanenitrile (3e) 
Prepared from 3-iodoquinoline (51.2 mg, 0.2 mmol) and 2-chloro-3-
phenylpropanenitrile (33.1 mg, 0.2 mmol) with NaBF4 (22 mg, 0.2 mmol) 
following General Procedure 3. The crude residue was purified by silica gel 
chromatography (0:100 to 30:70 EtOAc:hexanes) to yield 33.8 mg (65% yield) of 3e as a light 
N
CN
Bn
N
CN
tBu
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yellow solid.  The enantiomeric excess was determined to be 90% by chiral SFC analysis (AD, 
2.5 mL/min, 20% IPA in CO2, λ = 280 nm): tR(major) = 5.9 min, tR(minor) = 6.8 min. The 
product could be further enriched via recrystallization by vapor diffusion of pentane to a 
saturated solution of 3e in DCM, affording 29.7 mg (88% recovery) of clear pyramidal crystals 
suitable for X-Ray diffraction. The enantiomeric excess of recrystallized 3e was determined to be 
96%. The structure was solved by direct methods using SHELXS1 and refined against F2 on all 
data by full-matrix least squares with SHELXL-20142 using established refinement techniques 
and with an extinction coefficient of 0.0069(7).3 All non-hydrogen atoms were refined 
anisotropically. All hydrogen atoms were included into the model at geometrically calculated 
positions and refined using a riding model. Compound 3e crystallizes in the orthorhombic space 
group P212121 and absolute configuration was determined by anomalous dispersion (Flack = -
0.15(8)).1H NMR (500 MHz, Chloroform-d) δ 8.71 (d, J = 2.4 Hz, 1H), 8.16 – 8.10 (m, 1H), 
8.07 (d, J = 2.3 Hz, 1H), 7.81 (dd, J = 8.2, 1.4 Hz, 1H), 7.77 (ddd, J = 8.4, 6.9, 1.4 Hz, 1H), 7.61 
(ddd, J = 8.1, 6.9, 1.2 Hz, 1H), 7.33 – 7.27 (m, 3H), 7.17 – 7.11 (m, 2H), 4.32 – 4.25 (m, 1H), 
3.36 – 3.23 (m, 2H); 13C NMR (126 MHz, cdcl3) δ 149.35, 147.68, 135.32, 134.61, 130.18, 
129.35, 129.29, 128.84, 127.96, 127.80, 127.76, 127.49, 127.45, 119.51, 41.90, 37.50; IR 
(NaCl/thin film): 3029.15, 2925.55, 2855.78, 2242.14, 1604.24, 1571.67, 1495.10, 1455.39, 
1382.41, 1125.96, 908.49, 787.51, 752.04, 734.70, 699.30 cm-1; [α]D25 = -1.218 (c = 0.870, 
CHCl3). HRMS (MM) calc’d for [M+H]+ 259.1230, found 259.1427. 
 
 
Ethyl 4-cyano-4-(quinolin-3-yl)butanoate (3f) 
Prepared from 3-iodoquinoline (51.2 mg, 0.2 mmol) and ethyl 4-chloro-
4-cyanobutyrate (35.1 mg, 0.2 mmol) following General Procedure 3. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1	  Sheldrick, G. M. Acta Cryst. 1990, A46, 467. 2	  Sheldrick, G. M. Acta Cryst. 2008, A64, 112.	  
3Müller, P. Crystallography Reviews 2009, 15, 57.	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The crude residue was purified by silica gel chromatography (0:100 to 30:70 EtOAc:hexanes) to 
yield 34.0 mg (63% yield) of 3f as a clear oil.  The enantiomeric excess was determined to be 
80% by chiral SFC analysis (AD, 2.5 mL/min, 12% IPA in CO2, λ = 254 nm): tR(major) = 7.2 
min, tR(minor) = 8.3 min.  1H NMR (500 MHz, Chloroform-d) δ 8.91 (s, 1H), 8.20 (s, 2H), 7.86 
(dd, J = 8.2, 1.1 Hz, 1H), 7.77 (d, J = 6.7 Hz, 1H), 7.61 (dd, J = 8.1, 6.8 Hz, 1H), 4.28 (dd, J = 
8.7, 6.0 Hz, 1H), 4.15 (q, J = 7.1 Hz, 2H), 2.62 (dt, J = 16.9, 7.5 Hz, 1H), 2.53 (dt, J = 17.0, 6.5 
Hz, 1H), 2.41 – 2.21 (m, 2H), 1.27 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, cdcl3) δ 171.81, 
149.29, 148.04, 134.40, 130.30, 129.54, 128.12, 127.83, 127.61, 127.59, 119.40, 61.01, 34.27, 
30.92, 30.72, 14.17; IR (NaCl/thin film): 2979.77, 2926.59, 2242.45, 1731.81, 1495.27, 1377.67, 
1312.77, 1189.37, 1024.39, 909.00, 788.82, 754.73 cm-1; [α]D25 = -9.319 (c = 0.860, CHCl3). 
HRMS (MM) calc’d for [M+H]+ 269.1285, found 269.1313. 
 
 3-chloro-2-(quinolin-3-yl)propanenitrile (3g) 
Prepared from 3-iodoquinoline (102.4 mg, 0.4 mmol) and 2,4-
dichlorobutanenitrile (27.6 mg, 0.2 mmol) following General Procedure 3. 
The crude residue was purified by silica gel chromatography (0:100 to 
30:70 EtOAc:hexanes) to yield 35.8 mg (78% yield) of 3g as a clear oil that slowly solidified on 
standing.  The enantiomeric excess was determined to be 79% by chiral SFC analysis (AD, 2.5 
mL/min, 12% IPA in CO2, λ = 254 nm): tR(major) = 7.1 min, tR(minor) = 9.7 min.  1H NMR 
(500 MHz, Chloroform-d) δ 8.88 (d, J = 2.4 Hz, 1H), 8.22 (d, J = 2.4 Hz, 1H), 8.14 (dd, J = 8.5, 
1.0 Hz, 1H), 7.90 – 7.83 (m, 1H), 7.78 (ddd, J = 8.4, 6.9, 1.4 Hz, 1H), 7.63 (ddd, J = 8.1, 6.9, 1.2 
Hz, 1H), 4.41 (dd, J = 8.6, 6.7 Hz, 1H), 3.79 (ddd, J = 11.5, 8.2, 4.6 Hz, 1H), 3.60 (ddd, J = 11.4, 
6.4, 4.8 Hz, 1H), 2.54 (dddd, J = 14.4, 8.7, 6.5, 4.5 Hz, 1H), 2.40 (dddd, J = 14.4, 8.2, 6.7, 4.8 
Hz, 1H); 13C NMR (126 MHz, cdcl3) δ 149.09, 147.92, 134.63, 130.42, 129.44, 127.77, 127.71, 
127.51, 127.27, 119.08, 41.02, 38.07, 32.28; IR (NaCl/thin film): 2960.74, 2922.28, 2242.62, 
1571.06, 1495.00, 1443.08, 1382.69, 1125.91, 957.61, 906.20, 787.55, 753.85, 619.73 cm-1; [α]-
D
25 = +9.150 (c = 0.665, CHCl3). HRMS (MM) calc’d for [M+H3O]+ 249.0789, found 249.0270. 
 
tert-butyl-4-(2-cyano-2-(quinolin-3-yl)ethyl)piperidine-1-carboxylate (3h) 
Prepared from 3-iodoquinoline (51.2 mg, 0.2 mmol) and tert-Butyl-4-
(2-chloro-2-cyanoethyl)piperidine-1-carboxylate (54.6 mg, 0.2 mmol) 
N
CN
Cl
N
CNBocN
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following General Procedure 3. The crude residue was purified by silica gel chromatography 
(0:100 to 40:60 EtOAc:hexanes) to yield 44.7 mg (61% yield) of 3h as a clear oil.  The 
enantiomeric excess was determined to be 89% by chiral SFC analysis (AD, 2.5 mL/min, 25% 
IPA in CO2, λ = 280 nm): tR(major) = 4.8 min, tR(minor) = 6.0 min.  1H NMR (500 MHz, 
Chloroform-d) δ 8.81 (d, J = 2.3 Hz, 1H), 8.18 (d, J = 2.3 Hz, 1H), 8.12 (dd, J = 8.4, 1.0 Hz, 
1H), 7.84 (dd, J = 8.1, 1.4 Hz, 1H), 7.76 (ddd, J = 8.4, 6.9, 1.4 Hz, 1H), 7.60 (ddd, J = 8.1, 6.8, 
1.1 Hz, 1H), 4.10 (br, dd, J = 10.1, 5.6 Hz, 3H), 2.72 (br, 2H), 2.13 – 1.99 (m, 1H), 1.94 – 1.63 
(m, 4H), 1.46 (s, 9H), 1.33 – 1.12 (m, 2H); 13C NMR (126 MHz, cdcl3) δ 154.68, 149.12, 147.72, 
134.10, 130.21, 129.37, 128.78, 127.73, 127.60, 127.58, 119.77, 79.55, 43.88 (br), 43.20 (br), 
42.58, 33.99, 32.58, 32.10, 31.22, 28.44; IR (NaCl/thin film): 2974.27, 2926.66, 2852.75, 
2239.98, 1685.09, 1495.27, 1424.19, 1365.34, 1278.99, 1244.13, 1163.05, 1125.17, 970.82, 
865.20, 787.79, 755.04, 736.24, 620.45 cm-1; [α]D25 = -4.158 (c = 1.900, CHCl3). HRMS (MM) 
calc’d for [M+Mg]+ 389.1948, found 389.2091. 
 
tert-butyl-4-(cyano(quinolin-3-yl)methyl)piperidine-1-carboxylate (3i) 
Prepared from 3-iodoquinoline (51.2 mg, 0.2 mmol) and tert-Butyl-4-
(chloro(cyano)methyl)piperidine-1-carboxylate (51.8 mg, 0.2 mmol) 
following General Procedure 3. The crude residue was purified by silica 
gel chromatography (0:100 to 40:60 EtOAc:hexanes) to yield 28.6 mg (41% yield) of 3i as a 
clear oil.  The enantiomeric excess was determined to be 91% by chiral SFC analysis (AD, 2.5 
mL/min, 12% IPA in CO2, λ = 280 nm): tR(minor) = 18.5 min, tR(major) = 19.5 min.  1H NMR 
(500 MHz, Chloroform-d) δ 8.79 (d, J = 2.4 Hz, 1H), 8.16 (d, J = 2.3 Hz, 1H), 8.13 (dq, J = 8.5, 
0.8 Hz, 1H), 7.86 (dd, J = 8.1, 1.3 Hz, 1H), 7.77 (ddd, J = 8.4, 6.9, 1.4 Hz, 1H), 7.62 (ddd, J = 
8.1, 6.9, 1.2 Hz, 1H), 4.19 (s, 2H), 3.94 (d, J = 6.8 Hz, 1H), 2.64 (s, 2H), 2.03 (tdd, J = 12.0, 6.9, 
3.5 Hz, 1H), 1.88 – 1.71 (m, 1H), 1.67 (dt, J = 12.9, 3.0 Hz, 1H), 1.45 (s, 11H); 13C NMR (126 
MHz, cdcl3) δ 154.49, 149.48, 147.80, 135.05, 130.33, 129.37, 127.79, 127.66, 127.41, 126.70, 
118.57, 79.85, 43.53, 42.89, 41.41, 41.34, 30.11, 28.80, 28.40; IR (NaCl/thin film): 2975.09, 
2929.55, 2853.85, 2240.07, 1688.65, 1424.27, 1365.82, 1248.34, 1165.15, 1121.49, 1059.13, 
756.02 cm-1; [α]D25 = -21.275 (c = 0.640, CHCl3). HRMS (MM) calc’d for [M+Mg]+ 377.1948, 
found 377.2042. 
 
N
BocN
CN
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5-(thiophen-2-yl)pent-2-enenitrile (1:1 cis/trans) (12) 
Prepared from 2-iodothiophene (11 µL, 0.1 mmol) and 2-chloro-2-
cyclopropylacetonitrile (11.6 mg, 0.1 mmol) following General 
Procedure 3. The crude residue was purified by preperative thin layer chromatography (15:85 
EtOAc:hexanes) to yield 3.5 mg (21% yield) of 12 as a clear oil as a 1:1 mixture of cis* and 
trans§ isomers. Analysis of the crude NMR indicated no other conversion of the aryl iodide, with 
no cyclopropane-containing product detected. No unreacted chloronitrile was observed, 
presumably non-productive reaction pathways.  1H NMR (500 MHz, Chloroform-d) δ 7.16 (ddd, 
J = 5.1, 1.2, 0.7 Hz, 2H)* §, 6.94 (ddd, J = 5.2, 3.4, 1.9 Hz, 2H)* §, 6.86 – 6.77 (m, 2H)* §, 6.73 
(dt, J = 16.3, 6.9 Hz, 1H) §, 6.50 (dt, J = 10.9, 7.5 Hz, 1H)*, 5.45 – 5.27 (m, 2H) * §, 3.02 (dtd, J = 
15.6, 7.4, 0.8 Hz, 4H) * §, 2.87 – 2.78 (m, 2H)*, 2.62 (ddd, J = 7.7, 6.9, 1.7 Hz, 2H)  §. 13C NMR 
(126 MHz, cdcl3) δ 153.94, 153.14, 142.38, 142.30, 126.95, 124.91, 123.78, 123.76, 100.98, 
100.70, 35.11, 33.46, 28.43, 28.09; IR (NaCl/thin film): 2916.78, 2848.47, 2220.22, 1558.05, 
1683.13, 848.26, 689.00, 668.02 cm-1. HRMS (MM) calc’d for [M]+ 163.0450, found 163.0765. 
 
4. Synthesis of Enantioenriched Nitrile Derivatives. 
 
a. Hydrogenation of 7k over Raney Ni to Boc-amine 8. 
 
CN
N
N
N
Boc2O (1.5 equiv)
Raney Ni
H2 (1 atm), 23 ºC, 12 h N
N
N
NHBoc
 
Raney Ni (75 mg) was rinsed with dry MeOH 3 times to remove excess water and added to a 
flame-dried flask. To this was added dry MeOH (5 mL), 4-phenyl-2-(2-(piperidin-1-
yl)pyrimidin-5-yl)butanenitrile (7k, 30 mg, 0.10 mmol, 85% ee), and Boc anhydride (33 mg, 
0.15 mmol). The flask was purged with N2 for 15 min, then flushed with two balloons of H2. The 
flask was equipped with a balloon of H2 and stirred for 3.5 hours. The reaction was then filtered 
over Celite with EtOAc to afford a viscous resinous clear oil. The crude residue was purified by 
silica gel chromatography (0:100 to 50:50 EtOAc:hexanes) to yield 39 mg (95% yield) of 8 as a 
clear oil that solidified slowly upon standing.  The enantiomeric excess was determined to be 
CN
S
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85% by chiral SFC analysis (AD, 2.5 mL/min, 15% IPA in CO2, λ = 235 nm): tR(major) = 10.5 
min, tR(minor) = 12.3 min.  1H NMR (500 MHz, Chloroform-d) δ 8.14 (s, 2H), 7.29 – 7.21 (m, 
2H), 7.21 – 7.13 (m, 1H), 7.13 – 7.06 (m, 2H), 4.45 (s, 1H), 3.86 – 3.70 (m, 4H), 3.45 (dt, J = 
13.1, 6.4 Hz, 1H), 3.12 (ddd, J = 13.9, 8.8, 5.4 Hz, 1H), 2.69 – 2.41 (m, 3H), 1.99 (dddd, J = 
13.6, 9.8, 6.9, 4.8 Hz, 1H), 1.84 (dtd, J = 13.5, 9.8, 5.3 Hz, 1H), 1.74 – 1.55 (m, 6H), 1.40 (s, 
9H); 13C NMR (126 MHz, cdcl3) δ 161.26, 157.43, 155.82, 141.54, 128.42, 128.33, 125.93, 
121.66, 79.40, 46.02, 44.85, 40.52, 34.57, 33.28, 28.34, 25.75, 24.84; IR (NaCl/thin film): 
3337.97, 2930.35, 2853.42, 1712.79, 1602.18, 1504.75, 1449.34, 1364.47, 1271.22, 1255.54, 
1169.92, 1028.05, 947.36, 798.75, 699.89 cm-1; [α]D25 = -15.883 (c = 2.365, CHCl3). HRMS 
(MM) calc’d for [M]+ 410.2676, found 410.2101. 
 
b. Hydrolysis of XX with Ghaffar-Parkins catalyst to carboxamide 9. 
 
CN
N
N
N EtOH, H2O, 65 ºC, 36 h N
N
N
OH2N
Ghaffar-Parkins catalyst
(20 mol %)
 
In a 1-dram vial, 4-phenyl-2-(2-(piperidin-1-yl)pyrimidin-5-yl)butanenitrile (7k, 30 mg, 0.10 
mmol, 85% ee) was suspended in EtOH (0.4 mL) and H2O (0.1 mL). To this was added 
hydrido(dimethylphosphinous acid-kP)[hydrogen bis(dimethylphosphinito-kP)]platinum(II) (9 
mg, 20 µmol). The reaction was sealed with a Teflon-lined cap and heated to 65 ºC for 36 h. 
After cooling to room temperature, the reaction was diluted with DCM and filtered through a 
short plug of silica gel and Na2SO4. The plug was washed with additional DCM and the organics 
were concentrated to afford the carboxamide as a clear oil. The crude residue was purified by 
silica gel chromatography (30:70 to 60:40 EtOAc:hexanes) to yield 30.8 mg (95% yield) of 9 as 
a viscous clear oil.  The enantiomeric excess was determined to be 85% by 1H NMR using 
Europium(III) tris[3-(trifluoromethylhydroxymethylene)-d-camphorate] (30 mol %) as a chiral 
shift reagent.  1H NMR (500 MHz, Chloroform-d) δ 8.23 (s, 2H), 7.27 (d, J = 7.2 Hz, 2H), 7.22 – 
7.16 (m, 1H), 7.16 – 7.11 (m, 2H), 5.66 (s, 1H), 5.45 (s, 1H), 3.92 – 3.61 (m, 4H), 3.12 (dd, J = 
8.4, 6.8 Hz, 1H), 2.67 – 2.54 (m, 2H), 2.43 (ddt, J = 13.8, 8.7, 6.9 Hz, 1H), 2.12 – 1.97 (m, 1H), 
1.68 (td, J = 6.7, 6.3, 4.7 Hz, 2H), 1.65 – 1.55 (m, 4H); 13C NMR (126 MHz, cdcl3) δ 175.22, 
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161.24, 157.30, 140.84, 128.51, 126.13, 119.40, 46.14, 44.86, 34.06, 33.17, 25.72, 24.82; IR 
(NaCl/thin film): 3333.85, 3190.50, 2932.50, 2853.02, 1667.77, 1602.06, 1504.96, 1446.89, 
1364.61, 1271.06, 1256.15, 1178.28, 1024.54, 947.10, 797.03, 733.36, 699.53 cm-1 [α]D25 = 
+35.005 (c = 2.455, CHCl3). HRMS (MM) calc’d for [M]+ 324.1945, found 324.1904. 
 
c. DIBAL-H reduction of 7n to carboxaldehyde 10. 
 
CN DIBAL-H (1 M/hexanes)
(3 equiv)
DCM, -41 ºC, 20 min
OH
S S
 
To a flame-dried flask was added 4-phenyl-2-(thiophen-2-yl)butanenitrile (7n, 46 mg, 0.2 mmol, 
88% ee) and DCM (30 mL). The reaction was cooled to -41 ºC and a 1 M solution of DIBAL-H 
in hexanes (3 equiv, 0.6 mL, 0.6 mmol) was added slowly via syringe. The reaction was 
complete by TLC after 20 min. A 5% AcOH/H2O solution (12 mL) was added and the reaction 
was allowed to warm to room temperature. The reaction was stirred vigorously for 30 min and 
then the layers were separated. The organics were washed with dilute sodium bicarbonate, dried 
over sodium sulfate, and concentrated to afford light yellow oil. The crude residue was purified 
by silica gel chromatography (0:100 to 10:90 EtOAc:hexanes) to yield 44 mg (96% yield) of 10 
as a yellow oil that was stored frozen in benzene.  The enantiomeric excess was determined to be 
81% by chiral SFC analysis (AD, 2.5 mL/min, 8% IPA in CO2, λ = 235 nm): tR(minor) = 4.5 
min, tR(major) = 5.1 min.  1H NMR (500 MHz, Chloroform-d) δ 9.61 (d, J = 2.1 Hz, 1H), 7.34 – 
7.28 (m, 3H), 7.25 – 7.20 (m, 1H), 7.18 (dq, J = 7.6, 0.7 Hz, 2H), 7.07 (dd, J = 5.1, 3.5 Hz, 1H), 
6.95 (ddd, J = 3.5, 1.2, 0.7 Hz, 1H), 3.79 (ddd, J = 8.4, 6.3, 2.1 Hz, 1H), 2.73 (ddd, J = 14.4, 9.0, 
5.7 Hz, 1H), 2.64 (ddd, J = 13.8, 8.8, 7.0 Hz, 1H), 2.43 (dddd, J = 13.6, 9.0, 7.1, 6.3 Hz, 1H), 
2.17 – 2.07 (m, 1H); 13C NMR (126 MHz, cdcl3) δ 198.65, 140.80, 138.31, 128.54, 128.52, 
127.54, 126.43, 126.22, 125.56, 52.86, 32.84, 32.05; IR (NaCl/thin film): 3025.79, 2924.74, 
1725.05, 1496.21, 1454.03, 750.13, 699.05 cm-1; [α]D25 = +4.156 (c = 0.70, CHCl3). HRMS 
(MM) calc’d for [M]+ 410.2676, found 410.2101. 
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5. SFC traces for racemic and enantioenriched benzylic nitriles. 
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6. XRay crystallographic data for 3e.  
 
 
 
Table 1.  Crystal data and structure refinement for final_p15159. 
Identification code  p15159 
Empirical formula  C18 H14 N2 
Formula weight  258.31 
Temperature  100.01 K 
Wavelength  1.54178 Å 
Crystal system  Orthorhombic 
Space group  P212121 
Unit cell dimensions a = 7.8946(6) Å α= 90°. 
 b = 12.0793(9) Å β= 90°. 
 c = 14.7171(11) Å γ = 90°. 
Volume 1403.44(18) Å3 
Z 4 
Density (calculated) 1.223 Mg/m3 
Absorption coefficient 0.562 mm-1 
F(000) 544 
Crystal size 0.312 x 0.306 x 0.264 mm3 
Theta range for data collection 4.736 to 74.595°. 
Index ranges -9<=h<=9, -15<=k<=15, -17<=l<=18 
Reflections collected 33599 
Independent reflections 2860 [R(int) = 0.0298] 
Completeness to theta = 67.679° 100.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7538 and 0.6982 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2860 / 0 / 182 
Goodness-of-fit on F2 1.059 
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Final R indices [I>2sigma(I)] R1 = 0.0273, wR2 = 0.0712 
R indices (all data) R1 = 0.0277, wR2 = 0.0717 
Absolute structure parameter -0.15(8) 
Extinction coefficient 0.0069(7) 
Largest diff. peak and hole 0.163 and -0.104 e.Å-3 
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Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (Å2x 
103) for final_p15159.  U(eq) is defined as one third of  the trace of the orthogonalized Uij 
tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
N(1) 8035(2) 6345(1) 4866(1) 35(1) 
N(2) 5039(2) 7879(1) 7491(1) 34(1) 
C(3) 7089(2) 4720(1) 6140(1) 26(1) 
C(1) 6781(2) 6492(1) 5446(1) 36(1) 
C(8) 10236(2) 5159(1) 4296(1) 33(1) 
C(4) 8436(2) 4511(1) 5530(1) 26(1) 
C(6) 10643(2) 3339(1) 4937(1) 35(1) 
C(9) 8876(2) 5353(1) 4902(1) 28(1) 
C(7) 11094(2) 4176(1) 4313(1) 34(1) 
C(2) 6260(2) 5708(1) 6104(1) 29(1) 
C(5) 9347(2) 3505(1) 5534(1) 31(1) 
C(10) 4788(2) 5923(1) 6740(1) 29(1) 
C(11) 4913(2) 7029(1) 7161(1) 28(1) 
C(13) 1584(2) 5835(1) 6912(1) 31(1) 
C(12) 3056(2) 5786(2) 6257(1) 38(1) 
C(16) -1090(2) 5948(2) 8156(1) 46(1) 
C(14) 591(2) 6770(1) 6978(1) 41(1) 
C(17) -97(3) 5009(2) 8097(1) 47(1) 
C(15) -737(2) 6823(2) 7593(2) 50(1) 
C(18) 1232(2) 4954(1) 7483(1) 40(1) 
________________________________________________________________________________ 
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Table 3.   Bond lengths [Å] and angles [°] for  final_p15159. 
_____________________________________________________  
N(1)-C(1)  1.319(2) 
N(1)-C(9)  1.3710(19) 
N(2)-C(11)  1.1394(19) 
C(3)-H(3)  0.9500 
C(3)-C(4)  1.414(2) 
C(3)-C(2)  1.362(2) 
C(1)-H(1)  0.9500 
C(1)-C(2)  1.416(2) 
C(8)-H(8)  0.9500 
C(8)-C(9)  1.416(2) 
C(8)-C(7)  1.368(2) 
C(4)-C(9)  1.4172(19) 
C(4)-C(5)  1.412(2) 
C(6)-H(6)  0.9500 
C(6)-C(7)  1.412(2) 
C(6)-C(5)  1.364(2) 
C(7)-H(7)  0.9500 
C(2)-C(10)  1.515(2) 
C(5)-H(5)  0.9500 
C(10)-H(10)  1.0000 
C(10)-C(11)  1.4761(19) 
C(10)-C(12)  1.550(2) 
C(13)-C(12)  1.511(2) 
C(13)-C(14)  1.378(2) 
C(13)-C(18)  1.383(2) 
C(12)-H(12A)  0.9900 
C(12)-H(12B)  0.9900 
C(16)-H(16)  0.9500 
C(16)-C(17)  1.381(3) 
C(16)-C(15)  1.372(3) 
C(14)-H(14)  0.9500 
C(14)-C(15)  1.387(3) 
C(17)-H(17)  0.9500 
C(17)-C(18)  1.386(3) 
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C(15)-H(15)  0.9500 
C(18)-H(18)  0.9500 
 
C(1)-N(1)-C(9) 117.15(13) 
C(4)-C(3)-H(3) 120.2 
C(2)-C(3)-H(3) 120.2 
C(2)-C(3)-C(4) 119.57(13) 
N(1)-C(1)-H(1) 117.6 
N(1)-C(1)-C(2) 124.75(14) 
C(2)-C(1)-H(1) 117.6 
C(9)-C(8)-H(8) 119.7 
C(7)-C(8)-H(8) 119.7 
C(7)-C(8)-C(9) 120.50(13) 
C(3)-C(4)-C(9) 118.01(13) 
C(5)-C(4)-C(3) 122.30(13) 
C(5)-C(4)-C(9) 119.69(13) 
C(7)-C(6)-H(6) 119.9 
C(5)-C(6)-H(6) 119.9 
C(5)-C(6)-C(7) 120.17(14) 
N(1)-C(9)-C(8) 119.14(13) 
N(1)-C(9)-C(4) 122.28(13) 
C(8)-C(9)-C(4) 118.57(13) 
C(8)-C(7)-C(6) 120.61(14) 
C(8)-C(7)-H(7) 119.7 
C(6)-C(7)-H(7) 119.7 
C(3)-C(2)-C(1) 118.23(14) 
C(3)-C(2)-C(10) 119.68(13) 
C(1)-C(2)-C(10) 122.06(13) 
C(4)-C(5)-H(5) 119.8 
C(6)-C(5)-C(4) 120.45(14) 
C(6)-C(5)-H(5) 119.8 
C(2)-C(10)-H(10) 107.7 
C(2)-C(10)-C(12) 112.00(11) 
C(11)-C(10)-C(2) 111.31(12) 
C(11)-C(10)-H(10) 107.7 
C(11)-C(10)-C(12) 110.35(13) 
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C(12)-C(10)-H(10) 107.7 
N(2)-C(11)-C(10) 178.73(16) 
C(14)-C(13)-C(12) 120.94(15) 
C(14)-C(13)-C(18) 118.24(16) 
C(18)-C(13)-C(12) 120.79(15) 
C(10)-C(12)-H(12A) 109.1 
C(10)-C(12)-H(12B) 109.1 
C(13)-C(12)-C(10) 112.42(12) 
C(13)-C(12)-H(12A) 109.1 
C(13)-C(12)-H(12B) 109.1 
H(12A)-C(12)-H(12B) 107.9 
C(17)-C(16)-H(16) 120.7 
C(15)-C(16)-H(16) 120.7 
C(15)-C(16)-C(17) 118.68(17) 
C(13)-C(14)-H(14) 119.5 
C(13)-C(14)-C(15) 120.93(16) 
C(15)-C(14)-H(14) 119.5 
C(16)-C(17)-H(17) 119.7 
C(16)-C(17)-C(18) 120.64(16) 
C(18)-C(17)-H(17) 119.7 
C(16)-C(15)-C(14) 120.77(17) 
C(16)-C(15)-H(15) 119.6 
C(14)-C(15)-H(15) 119.6 
C(13)-C(18)-C(17) 120.73(16) 
C(13)-C(18)-H(18) 119.6 
C(17)-C(18)-H(18) 119.6 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
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Table 4.   Anisotropic displacement parameters  (Å2x 103) for final_p15159.  The anisotropic 
displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
N(1) 56(1)  27(1) 24(1)  1(1) 7(1)  1(1) 
N(2) 38(1)  33(1) 33(1)  -6(1) 3(1)  4(1) 
C(3) 34(1)  23(1) 22(1)  0(1) -2(1)  -6(1) 
C(1) 56(1)  26(1) 26(1)  -1(1) 5(1)  6(1) 
C(8) 42(1)  34(1) 23(1)  -1(1) 3(1)  -7(1) 
C(4) 32(1)  25(1) 21(1)  -3(1) -4(1)  -6(1) 
C(6) 34(1)  34(1) 37(1)  -3(1) -2(1)  4(1) 
C(9) 39(1)  26(1) 19(1)  -3(1) -1(1)  -5(1) 
C(7) 33(1)  41(1) 29(1)  -6(1) 2(1)  -2(1) 
C(2) 39(1)  27(1) 21(1)  -4(1) 1(1)  -3(1) 
C(5) 34(1)  27(1) 31(1)  1(1) -4(1)  -2(1) 
C(10) 38(1)  27(1) 23(1)  -2(1) -1(1)  0(1) 
C(11) 31(1)  30(1) 23(1)  -2(1) 1(1)  3(1) 
C(13) 33(1)  31(1) 30(1)  -5(1) -10(1)  -6(1) 
C(12) 43(1)  42(1) 27(1)  -7(1) -6(1)  -4(1) 
C(16) 35(1)  55(1) 48(1)  -12(1) 2(1)  -18(1) 
C(14) 35(1)  33(1) 56(1)  10(1) -5(1)  -3(1) 
C(17) 51(1)  44(1) 45(1)  8(1) -6(1)  -17(1) 
C(15) 32(1)  35(1) 83(1)  -6(1) 1(1)  -2(1) 
C(18) 46(1)  30(1) 46(1)  0(1) -6(1)  -3(1) 
______________________________________________________________________________ 
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Table 5.   Hydrogen coordinates (x 104) and isotropic  displacement parameters (Å2x 10 3) for 
final_p15159. 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(3) 6765 4175 6571 32 
H(1) 6184 7175 5420 43 
H(8) 10554 5717 3874 39 
H(6) 11244 2657 4941 42 
H(7) 12002 4056 3901 41 
H(5) 9054 2940 5955 37 
H(10) 4844 5361 7239 35 
H(12A) 2925 6379 5798 45 
H(12B) 3035 5067 5935 45 
H(16) -1999 5986 8577 55 
H(14) 819 7386 6597 50 
H(17) -327 4395 8480 56 
H(15) -1411 7474 7626 60 
H(18) 1909 4305 7454 49 
________________________________________________________________________________ 
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Table 6.  Torsion angles [°] for final_p15159. 
________________________________________________________________  
N(1)-C(1)-C(2)-C(3) -0.9(2) 
N(1)-C(1)-C(2)-C(10) -179.01(15) 
C(3)-C(4)-C(9)-N(1) -0.5(2) 
C(3)-C(4)-C(9)-C(8) 179.23(12) 
C(3)-C(4)-C(5)-C(6) -179.68(14) 
C(3)-C(2)-C(10)-C(11) 134.26(14) 
C(3)-C(2)-C(10)-C(12) -101.68(16) 
C(1)-N(1)-C(9)-C(8) -179.75(14) 
C(1)-N(1)-C(9)-C(4) 0.0(2) 
C(1)-C(2)-C(10)-C(11) -47.67(18) 
C(1)-C(2)-C(10)-C(12) 76.39(18) 
C(4)-C(3)-C(2)-C(1) 0.3(2) 
C(4)-C(3)-C(2)-C(10) 178.47(12) 
C(9)-N(1)-C(1)-C(2) 0.7(2) 
C(9)-C(8)-C(7)-C(6) -0.2(2) 
C(9)-C(4)-C(5)-C(6) -0.1(2) 
C(7)-C(8)-C(9)-N(1) -179.73(14) 
C(7)-C(8)-C(9)-C(4) 0.5(2) 
C(7)-C(6)-C(5)-C(4) 0.4(2) 
C(2)-C(3)-C(4)-C(9) 0.33(19) 
C(2)-C(3)-C(4)-C(5) 179.90(13) 
C(2)-C(10)-C(12)-C(13) 171.71(14) 
C(5)-C(4)-C(9)-N(1) 179.88(13) 
C(5)-C(4)-C(9)-C(8) -0.35(19) 
C(5)-C(6)-C(7)-C(8) -0.3(2) 
C(11)-C(10)-C(12)-C(13) -63.69(17) 
C(13)-C(14)-C(15)-C(16) 0.4(3) 
C(12)-C(13)-C(14)-C(15) -178.60(15) 
C(12)-C(13)-C(18)-C(17) 178.66(15) 
C(16)-C(17)-C(18)-C(13) -0.5(3) 
C(14)-C(13)-C(12)-C(10) 103.57(17) 
C(14)-C(13)-C(18)-C(17) 0.7(2) 
C(17)-C(16)-C(15)-C(14) -0.1(3) 
C(15)-C(16)-C(17)-C(18) 0.2(3) 
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C(18)-C(13)-C(12)-C(10) -74.31(19) 
C(18)-C(13)-C(14)-C(15) -0.7(2) 
________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
 
  	  
